Does Medicare Pay for the Pneumococcal Vaccine? Coverage, Costs, and Timing

Meta description: Learn whether Medicare covers pneumococcal vaccines, what you may pay, which vaccines are recommended, and how to check your vaccination history.

Yes. Original Medicare generally covers recommended pneumococcal vaccines under Part B, including the vaccine and its administration. People with Original Medicare usually pay nothing when they meet Medicare’s coverage rules and get the vaccine from a provider who accepts Medicare assignment. The specific vaccine and number of doses depend on a person’s age, health risks, and vaccination history. Medicare Advantage plans must cover Medicare Part B services, though plan networks and billing procedures may apply.

How Medicare Covers Pneumococcal Vaccines

Medicare Part B covers pneumococcal vaccination as a preventive service. Coverage can include the conjugate vaccines PCV15, PCV20, and PCV21, as well as the polysaccharide vaccine PPSV23 when it is part of the recommended schedule. The appropriate vaccine is determined by current clinical guidance and a person’s prior doses—not by choosing a vaccine based on price alone.

Medicare’s coverage is tied to recommendations from the Advisory Committee on Immunization Practices (ACIP), a federal panel that advises the Centers for Disease Control and Prevention (CDC). Recommendations can change as new vaccines become available and evidence develops. A clinician or pharmacist can check the current schedule and help identify which dose, if any, is due.

Part B and out-of-pocket costs

For a covered pneumococcal vaccine, a person with Original Medicare generally pays $0 when the provider accepts Medicare assignment. The Part B deductible and coinsurance do not apply to covered preventive vaccines in this situation. Assignment means the provider agrees to accept Medicare’s approved amount as full payment for the service.

Costs can differ if a provider does not accept assignment, bills the vaccine under a different benefit, or the service does not meet Medicare’s coverage requirements. Before the appointment, the patient can ask whether the office or pharmacy will bill the vaccine to Medicare Part B and whether the provider accepts assignment. The Medicare Summary Notice or plan explanation of benefits can help clarify a claim after it is processed.

Medicare Advantage plans

Medicare Advantage plans, also called Medicare Part C, must cover services covered by Original Medicare, including eligible Part B preventive vaccines. Many plans charge no cost sharing for recommended pneumococcal vaccination, but patients should check the plan’s rules. A plan may require use of an in-network provider or pharmacy, and the process for scheduling or billing can vary.

People with Medicare Advantage can contact the plan before vaccination to confirm the covered location and any referral or billing requirements. They should not assume that a vaccine will be billed through Part D just because it is given at a pharmacy; pneumococcal vaccines are generally covered under Part B when they meet Medicare’s rules.

Which Pneumococcal Vaccines Are Available?

Pneumococcal vaccines help protect against infections caused by Streptococcus pneumoniae, also called pneumococcus. These infections can include pneumonia, bloodstream infections, and meningitis. Vaccination reduces the risk of some pneumococcal disease, but it does not prevent every case of pneumonia or every infection caused by the bacterium.

Current adult pneumococcal vaccines include two types. Conjugate vaccines train the immune system to respond to specific pneumococcal types and include PCV15, PCV20, and PCV21. PPSV23 is a polysaccharide vaccine that covers a different set of types. Depending on a person’s history and medical circumstances, a schedule may use one vaccine or a sequence of vaccines.

Brand names may appear on a vaccine record or billing statement. PCV15 is marketed as Vaxneuvance, PCV20 as Prevnar 20, PCV21 as Capvaxive, and PPSV23 as Pneumovax 23. The brand alone does not establish whether another dose is needed; the timing and type of earlier doses matter.

Who Is Recommended to Get a Pneumococcal Vaccine?

CDC recommendations generally call for pneumococcal vaccination for all adults age 50 and older who have not received an appropriate pneumococcal conjugate vaccine, or whose vaccination history is unknown. Adults ages 19 through 49 may also be recommended to get vaccinated if they have certain medical conditions or other risk factors.

Risk factors can include chronic heart, lung, or liver disease; diabetes; cigarette smoking; alcohol use disorder; a weakened immune system; and certain conditions affecting the spleen or cerebrospinal fluid. A person’s particular circumstances can affect which vaccine is recommended and whether additional doses are appropriate. The CDC schedule and a healthcare professional’s assessment are more useful than age alone when determining the next step.

Medicare eligibility and vaccine recommendations are related but are not identical. Medicare Part B covers eligible preventive vaccination for beneficiaries, while clinical guidance determines which vaccine or sequence is recommended. A person should not get an extra dose simply because Medicare covers it; the clinician should first review the vaccination record and current guidance.

How Many Doses Does Medicare Cover?

There is no single dose count that applies to every Medicare beneficiary. Some adults may need one conjugate vaccine dose, while others may need a conjugate vaccine followed by PPSV23. People who have received earlier pneumococcal vaccines may have a different recommendation from those who have never been vaccinated.

For example, under current CDC guidance, adults who have not previously received a pneumococcal conjugate vaccine—or whose history is unknown—may receive PCV15, PCV20, or PCV21. When PCV15 is used, PPSV23 is generally recommended afterward. PCV20 and PCV21 generally do not require a subsequent PPSV23 dose for adults following that schedule. The recommended interval after PCV15 is typically one year, although a shorter minimum interval may be advised for certain people with immunocompromising conditions, a cochlear implant, or a cerebrospinal fluid leak.

Those examples do not cover every vaccination history. Someone who previously received PCV13, PPSV23, or a combination may need a different interval or may not need another dose. In some cases, additional vaccination is a shared clinical decision rather than a routine recommendation. The CDC’s current adult pneumococcal schedule and a clinician’s review should guide the decision.

Medicare’s preventive benefit can cover recommended doses when the person meets the applicable coverage criteria. It does not mean every possible repeat dose is automatically covered as medically appropriate. The provider should document the prior vaccine history and the reason for the dose, then bill Medicare under the correct benefit.

Where to Get the Vaccine and How to Avoid Billing Problems

Pneumococcal vaccines may be available through a doctor’s office, clinic, or participating pharmacy. Availability and billing arrangements differ by location. A clinic may administer the vaccine during a routine appointment, while a pharmacy may be able to check records and bill the appropriate Medicare benefit directly.

Before getting vaccinated, a beneficiary can take these steps:

• Gather vaccine records. Check a personal immunization card, the patient portal, pharmacy records, or a state immunization information system.
• Ask which dose is due. Tell the provider about prior PCV13, PCV15, PCV20, PCV21, or PPSV23 doses, including approximate dates if exact dates are unavailable.
• Confirm Medicare billing. Ask whether the location bills pneumococcal vaccination to Part B and accepts Medicare assignment, or whether Medicare Advantage network rules apply.
• Check the claim afterward. Review the Medicare Summary Notice or plan statement and contact the provider or plan if an unexpected charge appears.

Keeping an accurate vaccine record is particularly helpful when a person has received shots at multiple pharmacies or healthcare systems. Duplicate doses can be avoided when a provider can verify what was administered and when. If records are missing, the provider can use available documentation and current CDC guidance to decide how to proceed.

What to Do if Medicare Denies a Claim

A claim denial does not necessarily mean pneumococcal vaccines are excluded from Medicare. The issue may involve an incorrect billing code, a dose given too soon, missing documentation, a provider’s billing method, or a plan network requirement. The first step is to ask the provider’s billing office which vaccine and administration service were submitted and why the claim was denied.

People with Original Medicare can review the denial and appeal instructions in their Medicare Summary Notice. People enrolled in Medicare Advantage should follow the appeal directions provided by their plan. If the dispute concerns whether another dose is clinically appropriate, the provider may need to explain the vaccination history and the applicable recommendation.

Medicare Coverage Compared With Other Vaccine Benefits

Pneumococcal vaccines are generally a Part B preventive benefit, which distinguishes them from many vaccines commonly covered through Part D. The correct benefit can depend on the vaccine and the circumstances of administration. A pharmacy or provider should confirm the billing route rather than assuming all vaccines are handled the same way.

Medicare Part D also covers many vaccines recommended by ACIP, with no cost sharing for vaccines covered under the Inflation Reduction Act’s vaccine provisions. However, pneumococcal vaccination is generally covered under Part B when Medicare’s Part B requirements are met. If a claim is being routed through Part D, the beneficiary can ask the pharmacy or plan whether Part B billing is appropriate.

Common Questions About Medicare and Pneumococcal Vaccines

Does Medicare pay for Prevnar 20?

Medicare Part B generally covers PCV20, sold as Prevnar 20, when it is recommended for the beneficiary and billed according to Medicare rules. Original Medicare beneficiaries generally pay nothing for a covered preventive dose when the provider accepts assignment. Medicare Advantage members should check their plan’s network and billing requirements.

Does Medicare cover Pneumovax 23?

Part B can cover PPSV23 when it is recommended as part of the person’s vaccination schedule. Whether PPSV23 is appropriate depends on the vaccines previously received and the recommended interval. A healthcare professional should verify the schedule before administration.

Can a Medicare beneficiary get vaccinated at a pharmacy?

Often, yes, but not every pharmacy uses the same billing process or participates in every Medicare Advantage network. The pharmacy should confirm that it can bill the vaccine under the correct Medicare benefit. Checking this before the appointment can help prevent an unexpected bill.

Does Medicare cover a pneumococcal vaccine every year?

No. Pneumococcal vaccination is not generally an annual shot. The number and timing of doses depend on age, health risks, vaccine history, and current recommendations. A clinician can determine whether a person is due for a dose.

Reliable Sources for Current Coverage and Vaccine Guidance

Coverage and clinical recommendations can change. For the latest details, beneficiaries can consult Medicare.gov’s pneumococcal shots page, which explains Medicare coverage, and the CDC’s pneumococcal vaccine recommendations, which describe adult vaccination schedules. A Medicare Advantage member can also contact the plan directly, and anyone with questions about a personal vaccine history should ask a healthcare professional.